Relay Therapeutics (RLAY) Change in Account Payables (2019 - 2024)
Relay Therapeutics (RLAY) reported Change in Account Payables of -$4.3 million for Q3 2024, down 251.88% year-over-year from $2.8 million in Q4 2023, and down 234.17% quarter-over-quarter from $3.2 million in Q2 2024.
Relay Therapeutics (RLAY) Change in Account Payables (2019 - 2024) Analysis & Trends
Relay Therapeutics (RLAY) has 6 years of Change in Account Payables data on file, last reported at -$4.3 million in Q3 2024.
- Change in Account Payables for Q3 2024 came in at -$4.3 million, down 251.88% year-over-year; the trailing twelve-month figure through Sep 2024 was -$6.4 million (down 228.7% YoY), and the FY2023 annual result was -$2.4 million, down 220.36% from the prior year.
- Change in Account Payables slipped to -$4.3 million in Q3 2024 per RLAY's latest filing, from $3.2 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $4.6 million in Q3 2022 and troughed at -$5.4 million in Q4 2023.
- A 5-year average of -$46210.5 and a median of -$56000.0 in 2021 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2020 and 2022: Change in Account Payables jumped 1737.5% in 2020, then plunged 5950.0% in 2022.
- A 5-year view of Change in Account Payables shows it stood at $1.3 million in 2020, then jumped by 89.63% to $2.4 million in 2021, then dropped by 19.15% to $2.0 million in 2022, then tumbled by 373.21% to -$5.4 million in 2023, then advanced by 19.99% to -$4.3 million in 2024.
- Business Quant data shows RLAY's Change in Account Payables at -$4.3 million in Q3 2024, $3.2 million in Q2 2024, and $102000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -4.30 Mn |
| Sep 30, 2024 | -4.30 Mn |
| Jun 30, 2024 | 3.21 Mn |
| Jun 30, 2024 | 3.21 Mn |
| Mar 31, 2024 | 102,000.00 |
| Mar 31, 2024 | 102,000.00 |
| Dec 31, 2023 | -5.37 Mn |
| Dec 31, 2023 | -5.37 Mn |
| Sep 30, 2023 | -1.22 Mn |
| Sep 30, 2023 | -1.22 Mn |
| Jun 30, 2023 | 2.80 Mn |
| Jun 30, 2023 | 2.80 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Sep 30, 2022 | 4.63 Mn |
| Sep 30, 2022 | 4.63 Mn |
| Jun 30, 2022 | -3.39 Mn |
| Jun 30, 2022 | -3.39 Mn |